Expression of androgen receptors in primary breast cancer (Q43249156)

17 November 2017

Expression of androgen receptors in primary breast cancer (English)

1 reference

17 November 2017

S Park

1

1 reference

17 November 2017

J Koo

2

1 reference

17 November 2017

H S Park

3

1 reference

17 November 2017

J-H Kim

4

1 reference

17 November 2017

S-Y Choi

5

1 reference

17 November 2017

J H Lee

6

1 reference

17 November 2017

B-W Park

7

1 reference

17 November 2017

K S Lee

8

1 reference

17 November 2017

3 November 2009

1 reference

17 November 2017

1 reference

17 November 2017

21

1 reference

17 November 2017

3

1 reference

17 November 2017

488-492

1 reference

Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer

17 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

Targeted therapies in breast cancer: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

Therapeutic strategies for triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

Novel agents on the horizon for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

Androgen receptors as a prognostic and predictive factor in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

Prognostic markers in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

Expression of androgen receptors and inhibin/activin alpha and betaA subunits in breast apocrine lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

Expression of androgen, estrogen and progesterone receptors in mucinous carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

Elevated levels of HER-2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP510

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDP510

1 reference

17 November 2017

1 reference